Amneal Pharmaceuticals, Inc. Class A Common Stock Profile
About
Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.
Info & Links
CEO
Chirag Patel
Headquarters
400 CROSSING BOULEVARD BRIDGEWATER, NJ 08807, UNITED STATES
Amneal Pharmaceuticals, Inc. Class A Common Stock Statistics
Valuation Measures
Market Capitalization2
2.75B
Enterprise Value
5.21B
Enterprise Value/EBITDA(ttm)
12.44
Price to Earnings Ratio(ttm)
14.57
Price to Sales(ttm)
0.91
Price to Book(mrq)
--
Price to Cash(ytd)
5.83
Profitability
Gross Margin(ttm)
27.53%
Operating Margin(ttm)
6.29%
Profit Margin(ttm)
-3.27%
Return on Equity(ttm)
-346.26%
Return on Invested Capital(ttm)
-2.11%
Return on Assets(ttm)
4.85%
Income Statement
Revenue(ttm)
2.68B
Revenue Per Share(ttm)
8.65
Gross Profit(ttm)
947.39M
EBITDA(ttm)3
418.68M
Net Income Available to Common(ttm)
-184.45M
Diluted EPS(ttm)
-0.68
Share Statistics
Beta (5Y Monthly)
1.10
52-Week Change
67.33%
S&P 500 52-Week Change
12.74%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
309.84M
Dividend Yield
0.00%
Float4
227.55M
% Held by Insiders
26.56%
% Held by Institutions
31.82%
Balance Sheet
Total Cash(mrq)
78.34M
Total Cash Per Share(mrq)
0.25
Total Debt(mrq)
2.53B
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
--
Quick Ratio(mrq)
0.84%
Book Value Per Share(mrq)
--
Cash Flow
Operating Cash Flow Per Share(ytd)
--
Free Cash Flow(ytd)
0.00
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.